Details for New Drug Application (NDA): 078182
✉ Email this page to a colleague
The generic ingredient in DIVALPROEX SODIUM is divalproex sodium. There are eighteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
Summary for 078182
Tradename: | DIVALPROEX SODIUM |
Applicant: | Upsher Smith Labs |
Ingredient: | divalproex sodium |
Patents: | 0 |
Pharmacology for NDA: 078182
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 078182
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIVALPROEX SODIUM | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 078182 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8326 | 0615-8326-39 | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8326-39) |
DIVALPROEX SODIUM | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 078182 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8327 | 0615-8327-30 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8327-30) / 5 TABLET, DELAYED RELEASE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 125MG VALPROIC ACID | ||||
Approval Date: | Jul 29, 2008 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 250MG VALPROIC ACID | ||||
Approval Date: | Jul 29, 2008 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 500MG VALPROIC ACID | ||||
Approval Date: | Jul 29, 2008 | TE: | AB | RLD: | No |
Complete Access Available with Subscription